Answers are grounded in this paper and cite their sources.
SATB2 is a marker of osteoblastic differentiation in benign and malignant mesenchymal tumours. Although SATB2 is not specific for osteosarcoma, it has the potential to be a useful adjunct in some settings, particularly in the distinction between hyalinized collagen and osteoid.
No takes yet. Share an insight, caveat, or question.
Conner et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: